NCT02060019View on ClinicalTrials.gov

Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

administration of exforge 10/160mg for 3days. Next 7days administration of exforge 10/160mg and crestor 20mg.

Trial Locations (1)

Unknown

Kyungpook university hospital, Deagu

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY